what is better compounded semaglutide or tirzepatide & 2025: Safe Use Guide Trimi GLP-1 Review 2026: What
Description
Its glucose-dependent mechanism of action provides glycemic benefits while minimizing hypoglycemia risk in non-insulin users
Less commonly covered for weight loss unless medically justified
Shrikrishna V Acharya Endocrinologist 25 Years MBBS, MD, DM(Endocrinology), MRCP (Endocrinology) Bengaluru Apollo Clinic, JP nagar, Bengaluru (25+ Patients) Dr Ahmed Sayeed General Physician/ Internal Medicine Specialist 26 Years MBBS, M.D (GENERAL MEDICINE), MRCP (UK) Bengaluru Apollo Clinic, JP nagar, Bengaluru (25+ Patients) Dr Sakshi Gagneja Endocrinologist 7 Years DNB (Medicine Gold Medal), DrNB (Endocrinology ) Lucknow Apollomedics Super Speciality Hospital, Lucknow (25+ Patients) Consult Top Specialists Dr
Notably, this favourable glycaemic effect was not associated with increased risk for hypoglycaemia
The proportion of patients losing 20% or more of their body weight was 30% on the 5 mg dose and 57% on the 15 mg dose
Neither the Zepbound single-dose pens and vials nor Mounjaro will qualify
